ArticleHealth economics review2023

Cost-effectiveness in unstable economies: the case of sacubitril/valsartan in heart failure with reduced ejection fraction in Argentina.

Mariano A Giorgi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.